Kewaunee Scientific Corp Files 8-K/A Amendment
Ticker: KEQU · Form: 8-K/A · Filed: Jan 16, 2025 · CIK: 55529
| Field | Detail |
|---|---|
| Company | Kewaunee Scientific CORP /De/ (KEQU) |
| Form Type | 8-K/A |
| Filed Date | Jan 16, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $2.50, $55,000,000, $20,000,000, $10,000,000, $15,000,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, financial-statements, exhibits
TL;DR
Kewaunee Scientific filed an amendment to its 8-K, updating financial statements and exhibits.
AI Summary
Kewaunee Scientific Corporation filed an 8-K/A on January 16, 2025, to amend a previous filing. The amendment pertains to financial statements and exhibits, with the earliest event reported being November 1, 2024. The company, incorporated in Delaware, is headquartered in Statesville, North Carolina.
Why It Matters
This filing is an amendment to a previous report, indicating a correction or addition to previously disclosed information, which could be material for investors.
Risk Assessment
Risk Level: low — This is a routine amendment to a previous filing, not indicating new negative events.
Key Players & Entities
- Kewaunee Scientific Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Statesville, North Carolina (location) — Principal executive offices
- November 1, 2024 (date) — Date of earliest event reported
- January 16, 2025 (date) — Filing date
FAQ
What is the purpose of this 8-K/A filing?
This 8-K/A filing serves as an amendment to a previous report, specifically concerning financial statements and exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on November 1, 2024.
What is the company's state of incorporation?
The company, Kewaunee Scientific Corporation, is incorporated in Delaware.
Where are Kewaunee Scientific Corporation's principal executive offices located?
The principal executive offices are located at 2700 West Front Street, Statesville, North Carolina.
What is the filing date of this amended report?
This amended report was filed as of January 16, 2025.
Filing Stats: 1,280 words · 5 min read · ~4 pages · Grade level 12.2 · Accepted 2025-01-15 20:22:49
Key Financial Figures
- $2.50 — nge on which registered Common Stock, $2.50 par value KEQU The Nasdaq Global Ma
- $55,000,000 — l stock of Nu Aire from the Sellers for $55,000,000 in the aggregate, subject to certain cu
- $20,000,000 — erned by the Loan Agreement include: a $20,000,000 committed senior secured revolving line
- $10,000,000 — NC, in its discretion, by an additional $10,000,000; and a $15,000,000 term loan (the "Ter
- $15,000,000 — n, by an additional $10,000,000; and a $15,000,000 term loan (the "Term Loan"). Additiona
- $23,000,000 — eller Notes") in an aggregate amount of $23,000,000. The Seller Notes accrue interest at 8%
Filing Documents
- d915304d8ka.htm (8-K/A) — 34KB
- d915304dex231.htm (EX-23.1) — 2KB
- d915304dex991.htm (EX-99.1) — 249KB
- d915304dex992.htm (EX-99.2) — 307KB
- g915304g35v26.jpg (GRAPHIC) — 17KB
- 0001193125-25-007212.txt ( ) — 805KB
- kequ-20241101.xsd (EX-101.SCH) — 2KB
- kequ-20241101_lab.xml (EX-101.LAB) — 17KB
- kequ-20241101_pre.xml (EX-101.PRE) — 11KB
- d915304d8ka_htm.xml (XML) — 8KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (a) Financial statements of businesses acquired. The audited financial statements of Nu Aire as of and for the fiscal year ended September 30, 2024, including the related notes thereto, are filed herewith as Exhibit 99.1. (b) Pro forma financial information. The unaudited pro forma condensed combined balance sheet of the Company as of October 31, 2024, and the unaudited pro forma condensed combined statements of operations of the Company for the year ended April 30, 2024 and the six months ended October 31, 2024, including the related notes thereto, giving effect to the Acquisition and the Financing, are filed herewith as Exhibit 99.2. The unaudited pro forma financial information gives effect to the Acquisition and the Financing on the basis of, and subject to, the assumptions set forth in accordance with Article 11 of Regulation S-X. (d) Exhibits: Exhibit No. 23.1 Consent of Forvis Mazars, LLP 99.1 Audited financial statements of Nu Aire, Inc. as of and for the fiscal year ended September 30, 2024, including the related notes thereto. 99.2 Unaudited pro forma condensed combined balance sheet of the Company as of October 31, 2024, and the unaudited pro forma condensed combined statements of operations of the Company for the year ended April 30, 2024 and the six months ended October 31, 2024, including the related notes thereto. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. (Registrant) Kewaunee Scientific Corporation Date: January 15, 2025 /s/ Donald T. Gardner III Donald T. Gardner III Vice President, Finance and Chief Financial Officer